menu

Skin Cancer Treatment Market

Schedule Call

Skin Cancer Treatment Market

Skin Cancer Treatment Market by Type (Basal Cell Carcinoma, Squamous Cell Cancer, Melanoma, Others), by Therapy Type (Immunotherapy, Targeted Therapy, Radiotherapy, Chemotherapy, Others), and by End-user (Hospitals, Cancer Research Centers, Specialty Clinics) – Global Outlook & Forecast 2022-2030

GR - 607237 Category: Pharmaceuticals

Number of pages: 100  |  Report Format: PDF  |  Published date: October 07, 2022

Historical Years – 2020  |  Base Year – 2021  |  Forecasted Years – 2022-2030


Skin Cancer Treatment Market Scope

Report Attribute

Details

Market size value in 2021

US$ 9.20 billion

Revenue forecast in 2030

US$ 17.49 billion

Growth Rate

CAGR of 7.4% from 2022 to 2030

Base year for estimation

2021

Forecast period

2022-2030

Segments covered

Type, Therapy Type, End-Users, and Region.

Regional scope

North America, Europe, Asia Pacific, and the Rest of the World (ROW)

Report Overview

The global skin cancer treatment market was valued at US$ 9.20 billion in 2021 and is expected to witness a CAGR of 7.4% during the forecast period from 2022 to 2030

Market Fundamentals                                                                                          

Skin cancer is one of the highly prevalent medication conditions that occur in humans. Skin cancer occurs due to abnormal growth of the skin cells. It is classified into various types: melanoma, squamous, and basal cell carcinoma. Different treatments are used, such as chemotherapy, radiotherapy, phototherapy, etc. are deployed for the treatment of skin cancer. The increasing patient pool of skin cancer and improving rates of novel treatment approvals are majorly driving the global skin cancer treatment market. 

[453473]

Market Dynamics

The growth of the global skin cancer treatment market can be attributed to various factors, such as the increasing prevalence of skin cancer, growing awareness, and rising government initiatives about early diagnosis and treatment, along with recent approvals of novel therapies. Furthermore, a strong product pipeline and continuous launch of advanced drugs or medicines contribute to market development. But some challenges in this market can obstruct growth. These market restraints include the side effects of chemotherapy and radiotherapy and the consequent preference for surgical procedures to eliminate cancer. 

Market Ecosystem

The global skin cancer treatment market has been analyzed from four perspectives: type, therapy type, end-users, and region. 

Skin Cancer Treatment Market by Type

[6565345]

Different skin cancers include basal cell carcinoma, squamous cell cancer, melanoma, and others (lymphoma, Kaposi sarcoma, etc.). Melanoma is the most common type of skin cancer found worldwide and thus dominates the market with the largest revenue share. The abnormal growth of melanocytes (in melanin cells) leads to this condition. It can occur due to exposure to ultraviolet radiation, tanning beds/lamps, or genetic factors. Additionally, basal cell carcinoma occupies the second-largest revenue share in the market because of the growing prevalence rate.   

Skin Cancer Treatment Market by Therapy Type

Based on the therapy type, the global skin cancer treatment market has been categorized into immunotherapy, targeted therapy, radiotherapy, chemotherapy, and others (photodynamic therapy, biological therapy, cryotherapy, etc.). Chemotherapy occupies the largest revenue share in the global skin cancer treatment market. This therapy has been providing better results with reduced reoccurrence risk. Chemotherapy uses drugs that travel throughout the body and avoid metastasis by destroying the cancer cells that may have spread in different body parts.

In addition, immunotherapy has gained notable popularity in the global market for skin cancer treatment. Immunotherapy boosts the immune system's ability to recognize, target, and eliminate cancerous cells, thus making it a more compatible and convenient method for treating cancer.

Skin Cancer Treatment Market by End User

The global skin cancer treatment market has been segmented based on end-users into hospitals, cancer research centers, and specialty clinics. Hospitals hold the highest revenue share in the market. The growth of this segment can be attributed to the increased preference rate of hospitals as it is considered the primary healthcare facility with a large footfall of patients. Also, advanced infrastructure and the availability of better physicians and treatment facilities make this segment a preferred treatment avenue, thus helping the market expand.

Skin Cancer Market by Region

The global skin cancer treatment market has been segmented based on regions: North America, Europe, Asia Pacific, and the Rest of the World. North America dominates the global market mainly due to the rising target patient base and increasing penetration of market players. Furthermore, evolution in technologies/treatments and continual approval of cancer drugs also contribute to market growth in North America. Europe holds the second-largest revenue share in the skin cancer treatment market. This is due to the developed healthcare infrastructure and the rapid adoption of advanced technologies and drugs.

The Asia Pacific is the fastest-growing region in the skin cancer treatment market. The fast pace of the Asia Pacific market is attributed to the growing prevalence of skin cancer, rapidly evolving healthcare infrastructure, and improving availability of new treatments. In addition, the increasing approvals of drugs and medicines and growing government initiatives further accelerate skin cancer treatment expansion in the Asia Pacific.

Competitive Landscape

Some prominent players operating in the global skin cancer treatment market are: 

  • Regeneron Pharmaceuticals, Inc.
  • Amgen Inc.
  • Pfizer Inc.
  • Bristol-Myers Squibb Company
  • CRS Holdings LLC. 
  • Sun Pharmaceutical Industries Ltd.
  • Merck & Co.
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • GlaxoSmithKline plc.

Strategic Developments

  • In April 2022, Regeneron acquired Checkmate Pharmaceuticals for $250 million, thus, acquiring the leading immuno-oncology drug called vidutolimod. This acquisition was made to enhance Regeneron’s product portfolio.
  • In June 2019, Pfizer announced its acquisition of Array Biopharma for US$ 10.64 billion in cash. This has allowed Pfizer to access Array’s FDA-approved skin cancer drug and pipeline cancer treatments. 
  • In April 2019, Bristol-Myers Squibb announced its acquisition of Celgene with US$ 74 billion. This acquisition was established to strengthen the company profile of Bristol-Myers Squibb in the skin cancer market.

Frequently Asked Questions About This Report

The Asia Pacific is the fastest-growing region in the skin cancer treatment market.

The estimated market size of the skin cancer treatment market in 2030 is US$ 17.49 billion.

The global skin cancer treatment market is estimated to grow at a CAGR of 7.4 from 2022 to 2030.

The key players in the skin cancer treatment market are Regeneron Pharmaceuticals, Inc., Amgen Inc., Pfizer Inc., Bristol-Myers Squibb Company, CRS Holdings LLC. , Sun Pharmaceutical Industries Ltd., Merck & Co., F. Hoffmann-La Roche Ltd., Novartis AG, GlaxoSmithKline plc., etc.

Table of Content

  1. INTRODUCTION
    1. Market Ecosystem 
    2. Timeline Under Consideration
      1. Historical Years – 2020
      2. Base Year – 2021
      3. Forecasted Years – 2022 to 2030
    3. Currency Used in the Report
  2. RESEARCH METHODOLOGY 
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
    4. Market Estimation Approach
      1. Bottom Up 
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions       
  3. PREMIUM INSIGHTS
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2021)
  4. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
  5. GLOBAL SKIN CANCER TREATMENT MARKET- ANALYSIS & FORECAST, BY TYPES
    1. Basal Cell Carcinoma
    2. Squamous Cell Cancer
    3. Melanoma
    4. Others (Lymphoma, Kaposi Sarcoma, etc.)
  6. GLOBAL SKIN CANCER TREATMENT MARKET- ANALYSIS & FORECAST, BY THERAPY TYPE
    1. Immunotherapy
    2. Targeted Therapy
    3. Radiotherapy
    4. Chemotherapy
    5. Others (Photodynamic Therapy, Biological Therapy, Cryotherapy, etc.)
  7. GLOBAL SKIN CANCER TREATMENT MARKET- ANALYSIS & FORECAST, BY END-USER
    1. Hospitals
    2. Cancer Research Centers
    3. Specialty Clinics
  8. GLOBAL SKIN CANCER TREATMENT MARKET- ANALYSIS & FORECAST, BY REGION
    1. North America Skin Cancer Treatment Market
      1. North America Skin Cancer Treatment Market, by Types
      2. North America Skin Cancer Treatment Market, by Therapy Type
      3. North America Skin Cancer Treatment Market, by End-User
      4. North America Skin Cancer Treatment Market, by Country
        1. U.S.
          1. U.S. Skin Cancer Treatment Market, by Type
          2. U.S. Skin Cancer Treatment Market, by Therapy Type
          3. U.S. Skin Cancer Treatment Market, by End-User
        2. Canada
          1. Canada Skin Cancer Treatment Market, by Type
          2. Canada Skin Cancer Treatment Market, by Therapy Type
          3. Canada Skin Cancer Treatment Market, by End-User
    2. Europe Skin Cancer Treatment Market
      1. Europe Skin Cancer Treatment Market, by Type
      2. Europe Skin Cancer Treatment Market, by Therapy Type
      3. Europe Skin Cancer Treatment Market, by Country/Region
        1. Germany
          1. Germany Skin Cancer Treatment Market, by Type
          2. Germany Skin Cancer Treatment Market, by Therapy Type
          3. Germany Skin Cancer Treatment Market, by End-User
        2. France
          1. France Skin Cancer Treatment Market, by Type
          2. France Skin Cancer Treatment Market, by Therapy Type
          3. France Skin Cancer Treatment Market, by End-User
        3. Spain
          1. Spain Skin Cancer Treatment Market, by Type
          2. Spain Skin Cancer Treatment Market, by Therapy Type
          3. Spain Skin Cancer Treatment Market, by End-User
        4. Italy
          1. Italy Skin Cancer Treatment Market, by Type
          2. Italy Skin Cancer Treatment Market, by Therapy Type
          3. Italy Skin Cancer Treatment Market, by End-User
        5. Rest of Europe
          1. Rest of Europe Skin Cancer Treatment Market, by Type
          2. Rest of Europe Skin Cancer Treatment Market, by Therapy Type
          3. Rest of Europe Skin Cancer Treatment Market, by End-User
    3. Asia Pacific Skin Cancer Treatment Market
      1. Asia Pacific Skin Cancer Treatment Market, by Type
      2. Asia Pacific Skin Cancer Treatment Market, by Therapy Type
      3. Asia Pacific Skin Cancer Treatment Market, by End-User
      4. Asia Pacific Skin Cancer Treatment Market, by Country/Region
        1. China
          1. China Skin Cancer Treatment Market, by Type
          2. China Skin Cancer Treatment Market, by Therapy Type
          3. China Skin Cancer Treatment Market, by End-User
        2. Japan
          1. Japan Skin Cancer Treatment Market, by Type
          2. Japan Skin Cancer Treatment Market, by Therapy Type
          3. Japan Skin Cancer Treatment Market, by End-User
        3. India
          1. India Skin Cancer Treatment Market, by Type
          2. India Skin Cancer Treatment Market, by Therapy Type
          3. India Skin Cancer Treatment Market, by End-User
        4. South Korea
          1. South Korea Skin Cancer Treatment Market, by Type
          2. South Korea Skin Cancer Treatment Market, by Therapy Type
          3. South Korea Skin Cancer Treatment Market, by End-User
        5. Australia
          1. Australia Skin Cancer Treatment Market, by Type
          2. Australia Skin Cancer Treatment Market, by Therapy Type
          3. Australia Skin Cancer Treatment Market, by End-User
        6. Rest of Asia Pacific 
          1. Rest of Asia Pacific Skin Cancer Treatment Market, by Type
          2. Rest of Asia Pacific Skin Cancer Treatment Market, by Therapy Type
          3. Rest of Asia Pacific Skin Cancer Treatment Market, by End-User
    4. Rest of the World Skin Cancer Treatment Market
      1. Rest of the World Skin Cancer Treatment Market, by Type
      2. Rest of the World Skin Cancer Treatment Market, by Therapy Type
      3. Rest of the World Skin Cancer Treatment Market, by End-User
      4. Rest of the World Skin Cancer Treatment Market, by Region
        1. Latin America
          1. Latin America Skin Cancer Treatment Market, by Type
          2. Latin America Skin Cancer Treatment Market, by Therapy Type
          3. Latin America Skin Cancer Treatment Market, by End-User
        2. Middle East & Africa
          1. Middle America & Africa Skin Cancer Treatment Market, by Type
          2. Middle America & Africa Skin Cancer Treatment Market, by Therapy Type
          3. Middle America & Africa Skin Cancer Treatment Market, by End-User
  9. COMPANY PROFILES   
    1. Regeneron Pharmaceuticals, Inc.
      1. Business Snapshot 
      2. Product Offered
      3. Financial Details
      4. Strategic Development
    2.  Amgen Inc.
    3.  Pfizer Inc.
    4.  Bristol-Myers Squibb Company
    5.  CRS Holdings LLC. 
    6.  Sun Pharmaceutical Industries Ltd.
    7.   Merck & Co.
    8.  F. Hoffmann-La Roche Ltd.
    9.  Novartis AG
    10. GlaxoSmithKline plc.

*Insights on financial performance is subject to availability of information in public domain


Single User License
Single User License
Multi User License
Enterprise User License
$4,750.00
Provides access to one user only and should not be shared with other employees within the organization.
Provides access to up to five users within the department or an organization.
Provides access to all the employees in the organization. The report can also be shared with subsidiaries, sister concerns and group entities.
Grants user/users’ access to quantitative data only, which includes but is not restricted to numeric data, tables, and charts as defined by Growth+ Reports.
  • What are the significant driving and restraining factors for the Skin Cancer Treatment Market?
  • Who are the leading companies in the market?
  • Where can you find the updates on recent developments by market players?
  • When is the right time to get discounts on complete market reports?
  • Why to invest in the Skin Cancer Treatment Market?
  • How to improve your organizational performance?
  • How to shift customers towards your brand?

Recommended Reports